In early-stage biotech, there’s always too much to do: experiments to run, documents to prepare, investors to update.
The real challenge isn’t deciding what to do next — it’s deciding what really matters.
From my work with biotech founders, three milestones consistently stand out as critical:
- Scientific proof points
- Clear experiments showing your concept works.
- These drive credibility with both investors and partners.
- Regulatory gates
- Submission-ready documents.
- Approvals that open the door to the next phase.
- Funding readiness
- Reports and data packaged for investor updates.
- Evidence that resources are being used efficiently.
When these three aren’t tracked with discipline, projects drift. And in biotech, drifting usually means running out of cash before results can be proven.
💡 One way to stay on track: use a Scientific Milestone Breakdown template.
It helps you:
✔️ Map scientific milestones alongside regulatory and funding gates.
✔️ Assign clear owners and deadlines.
✔️ Spot gaps early before they turn into delays.
Because success in biotech isn’t just about what you discover — it’s about whether you can prove it, document it, and fund it before time runs out.
coaching-vision.com 